CinCor Pharma Valuation
| CINCDelisted Stock | USD 29.06 0.00 0.00% |
At this time, the firm appears to be overvalued. CinCor Pharma shows a prevailing Real Value of $20.92 per share. The current price of the firm is $29.06. Our model approximates the value of CinCor Pharma from analyzing the firm fundamentals such as Return On Equity of -0.27, shares owned by insiders of 11.99 %, and Current Valuation of 7.93 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that CinCor Pharma's price fluctuation is very steady at this time. Calculation of the real value of CinCor Pharma is based on 3 months time horizon. Increasing CinCor Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for CinCor Pharma is useful when determining the fair value of the CinCor stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of CinCor Pharma. Since CinCor Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CinCor Stock. However, CinCor Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.06 | Real 20.92 | Hype 29.06 | Naive 33.95 |
The real value of CinCor Stock, also known as its intrinsic value, is the underlying worth of CinCor Pharma Company, which is reflected in its stock price. It is based on CinCor Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of CinCor Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CinCor Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CinCor Pharma helps investors to forecast how CinCor stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CinCor Pharma more accurately as focusing exclusively on CinCor Pharma's fundamentals will not take into account other important factors: CinCor Pharma Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining CinCor Pharma's current stock value. Our valuation model uses many indicators to compare CinCor Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CinCor Pharma competition to find correlations between indicators driving CinCor Pharma's intrinsic value. More Info.CinCor Pharma is number one stock in price to book category among related companies. It is number one stock in net asset category among related companies making up about 138,055,611 of Net Asset per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value CinCor Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CinCor Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CinCor Pharma's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CinCor Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CinCor Pharma and how it compares across the competition.
About CinCor Pharma Valuation
The delisted stock valuation mechanism determines the current worth of CinCor Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of CinCor Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CinCor Pharma based exclusively on its fundamental and basic technical indicators. By analyzing CinCor Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of CinCor Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CinCor Pharma. We calculate exposure to CinCor Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CinCor Pharma's related companies.CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts. Cincor Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.
8 Steps to conduct CinCor Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CinCor Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CinCor Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CinCor Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CinCor Pharma's revenue streams: Identify CinCor Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CinCor Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CinCor Pharma's growth potential: Evaluate CinCor Pharma's management, business model, and growth potential.
- Determine CinCor Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CinCor Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CinCor Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as CinCor Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 35.4 M | |
| Retained Earnings | -77.7 M | |
| Retained Earnings Total Equity | -77.7 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in CinCor Stock
If you are still planning to invest in CinCor Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CinCor Pharma's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |